In 2017, Maya R. Said, Sc.D., founded Outcomes4Me after a personal health scare while leading global access and policy for oncology at Novartis revealed a critical gap in cancer care. She realized that despite tremendous innovation in drug discovery, patients struggled to understand their treatments and access the care they needed. Even with premium insurance and a network of medical professionals, navigating the healthcare system proved confusing and overwhelming. This experience inspired her to create a platform that would democratize healthcare by putting patients at the center of their care journey.
Outcomes4Me is now the first and only direct-to-patient, AI-driven platform that integrates with the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). The platform uses artificial intelligence and machine learning to translate complex clinical guidelines, written by and for oncologists at the world's leading cancer centers, into easy-to-understand, personalized guidance for cancer patients. Through a free mobile app and web platform, Outcomes4Me provides patients with personalized treatment options, genetic and genomic testing opportunities, symptom tracking, clinical trial matching, understandable health records, and access to a supportive peer community - empowering them to take control of their cancer care with evidence-based, oncologist-approved information.